TheraRadar
← Back
Data updated: Mar 29, 2026

BEDFORD LABS

OncologyInfectious DiseaseCardiovascular
Generics

BEDFORD LABS is a generic drug manufacturer focused on Oncology, Infectious Disease, Cardiovascular.

1982
Since
25
Drugs
-
Trials
187
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

CEFAZOLIN SODIUM 2026-02-13
Efficacy
FLUOROURACIL 2026-02-10
Labeling
SULFAMETHOXAZOLE AND TRIMETHOPRIM 2026-02-10
Labeling
FLUOROURACIL 2026-02-10
Labeling
FLUOROURACIL 2026-02-05
Labeling
FLUOROURACIL 2026-02-05
Labeling
FLUOROURACIL 2026-02-05
Labeling
FLUOROURACIL 2026-02-05
Labeling
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Oncology 33%
2 drugs
Infectious Disease 17%
1 drugs
Cardiovascular 17%
1 drugs
Gastroenterology 17%
1 drugs
Dermatology 17%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Pfizer big-pharma
Oncology, Infectious Disease, Dermatology, Gastroenterology
Baxter specialty
Infectious Disease, Cardiovascular, Oncology, Dermatology
COSETTE other
Cardiovascular, Dermatology, Infectious Disease, Oncology
CASPER PHARMA LLC big-pharma
Infectious Disease, Oncology, Cardiovascular, Gastroenterology, Dermatology
FOUGERA PHARMS other
Dermatology, Infectious Disease, Oncology, Cardiovascular